Published in Rev Bras Psiquiatr on March 01, 2010
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology (2011) 1.41
Improving the efficacy of translational medicine by optimally integrating health care, academia and industry. Nat Med (2011) 0.86
Psychotic symptoms in social anxiety disorder patients: report of three cases. Int Arch Med (2011) 0.80
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report. Hum Psychopharmacol (2013) 0.80
Panic attack triggering myocardial ischemia documented by myocardial perfusion imaging study. A case report. Int Arch Med (2012) 0.75
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med (2005) 2.25
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord (2007) 1.78
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Mitochondrial dysfunction and psychiatric disorders. Neurochem Res (2008) 1.73
Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med (2008) 1.65
Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med (2005) 1.63
Neuroimaging in social anxiety disorder: a systematic review of the literature. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.55
Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit Care Med (2004) 1.54
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health (2007) 1.52
Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med (2007) 1.50
Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania. J Psychopharmacol (2012) 1.44
Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder. Rev Bras Psiquiatr (2009) 1.41
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology (2011) 1.41
Duloxetine in the treatment of social anxiety disorder. J Clin Psychopharmacol (2007) 1.40
Cognitive impairment in a Brazilian sample of patients with bipolar disorder. Rev Bras Psiquiatr (2008) 1.39
Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res (2010) 1.37
Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett (2007) 1.35
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord (2009) 1.32
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol (2008) 1.30
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.28
Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res (2011) 1.24
The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol (2007) 1.19
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18
Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int (2009) 1.13
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci (2006) 1.11
Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry (2013) 1.11
Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res (2010) 1.10
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci (2006) 1.08
[Factorial structure of the Brazilian version of the Modified Reasons for Smoking Scale]. Rev Assoc Med Bras (2009) 1.08
Cannabidiol monotherapy for treatment-resistant schizophrenia. J Psychopharmacol (2006) 1.08
Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav Brain Res (2005) 1.07
Functional impairment and disability across mood states in bipolar disorder. Value Health (2010) 1.06
Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord (2009) 1.06
Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Crit Care Med (2006) 1.04
Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.04
Temporary inactivation reveals an essential role of the dorsal hippocampus in consolidation of object recognition memory. Neurosci Lett (2006) 1.03
Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf (2011) 1.03
Psychiatric disorders in asthmatic outpatients. Psychiatry Res (2002) 1.03
Altered gray matter morphometry and resting-state functional and structural connectivity in social anxiety disorder. Brain Res (2011) 1.03
Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.03
The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr (2009) 1.02
Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin Cancer Res (2006) 1.02
Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int (2008) 1.02
The serum S100B concentration is age dependent. Clin Chem (2002) 1.01
Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother (2011) 0.99
TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.99
Development and use of a biological rhythm interview. J Affect Disord (2009) 0.99
Inhibition of mTOR by rapamycin in the amygdala or hippocampus impairs formation and reconsolidation of inhibitory avoidance memory. Neurobiol Learn Mem (2011) 0.99
Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp Gerontol (2005) 0.99
Inflammation biomarkers and delirium in critically ill patients. Crit Care (2014) 0.98
Functional impact of biological rhythm disturbance in bipolar disorder. J Psychiatr Res (2009) 0.98
Il1-β involvement in cognitive impairment after sepsis. Mol Neurobiol (2013) 0.97
Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatr Res (2008) 0.97
Differential effects of emotional arousal in short- and long-term memory in healthy adults. Neurobiol Learn Mem (2003) 0.97
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol (2012) 0.97
Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.97
Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry (2014) 0.96
Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. Neuro Oncol (2014) 0.96
Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care (2010) 0.96
Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev (2010) 0.95
The impact of co-morbid alcohol use disorder in bipolar patients. Alcohol (2008) 0.94
Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord (2006) 0.94
Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis. Schizophr Res (2010) 0.94
Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2008) 0.94
Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats. Behav Brain Res (2011) 0.93
Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats. Crit Care (2008) 0.93
Adrenergic enhancement of consolidation of object recognition memory. Neurobiol Learn Mem (2007) 0.93
Long-term cognitive impairment in sepsis survivors. Crit Care Med (2005) 0.93
Antipsychotic-induced oxidative stress in rat brain. Neurotox Res (2008) 0.93
Mitochondrial respiratory chain and creatine kinase activities in rat brain after sepsis induced by cecal ligation and perforation. Mitochondrion (2008) 0.93
Structural magnetic resonance imaging in anxiety disorders: an update of research findings. Rev Bras Psiquiatr (2008) 0.92
Long-term memory for aversive training is impaired in Idua(-/-) mice, a genetic model of mucopolysaccharidosis type I. Brain Res (2006) 0.92
Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord (2009) 0.92
Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis. Mol Neurobiol (2013) 0.92
Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis. Intensive Care Med (2011) 0.91
DNA damage in rats after treatment with methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.91
Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence. Clinics (Sao Paulo) (2013) 0.91
Reversion of age-related recognition memory impairment by iron chelation in rats. Neurobiol Aging (2007) 0.91
Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behav Immun (2009) 0.91
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.91
Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol (2008) 0.91